FREE NEJM E-TOC    HOME   |   SUBSCRIBE   |   CURRENT ISSUE   |   PAST ISSUES   |   COLLECTIONS   |   Search Term  Advanced Search

Sign in | Get NEJM's E-Mail Table of Contents — Free | Subscribe

Previous Volume 335:1160-1161 October 10, 1996 Number 15 Next

	Since this article has no abstract, we have provided an extract of the first 100 words of the full text and any section headings.

	Full Text Purchase this article Add to Personal Archive Add to Citation Manager Notify a Friend E-mail When Cited Related Article by Schömig, A.

To the Editor: Schömig et al. (April 25 issue)¹ report that they did not observe neutropenia in any of the 257 patients receiving short-term ticlopidine therapy after coronary stenting. The authors note that in the literature, all reported cases of neutropenia were fully reversible and had developed in the second and third month of long-term therapy with ticlopidine. For these reasons, Schömig et al. consider the possible side effect of neutropenia with short-term ticlopidine therapy to be of little clinical importance. We do not agree with this view because of our clinical experience and other reports in the Journal² not . . . [Full Text of this Article]

References

HOME  |  SUBSCRIBE  |  SEARCH  |  CURRENT ISSUE  |  PAST ISSUES  |  COLLECTIONS  |  PRIVACY  |  TERMS OF USE  |  HELP  |  beta.nejm.org Comments and questions? Please contact us. The New England Journal of Medicine is owned, published, and copyrighted © 2009 Massachusetts Medical Society. All rights reserved.